Greenhawt, Matthew http://orcid.org/0000-0002-2365-9372
Kimball, Spencer
DunnGalvin, Audrey
Abrams, Elissa M.
Shaker, Marcus S.
Mosnaim, Giselle
Comberiati, Pasquale
Nekliudov, Nikita A
Blyuss, Oleg
Teufel, Martin
Munblit, Daniel
Article History
Received: 24 August 2020
Accepted: 22 December 2020
First Online: 24 February 2021
Compliance with Ethical Standards
:
: Matthew Greenhawt was supported by grant #5K08HS024599-02 from the Agency for Healthcare Research and Quality which ended after the study was completed but before manuscript submission; is an expert panel and coordinating committee member of the NIAID-sponsored Guidelines for Peanut Allergy Prevention; has served as a consultant for the Canadian Transportation Agency, Thermo Fisher, Intrommune, and Aimmune Therapeutics; is a member of physician/medical advisory boards for Aimmune Therapeutics, DBV Technologies, Sanofi/Genzyme, Genentech, Nutricia, Kaleo Pharmaceutical, Nestle, Acquestive, Allergy Therapeutics, Pfizer, US World Meds, Allergenis, Aravax, and Monsanto; is a member of the scientific advisory council for the National Peanut Board; has received honorarium for lectures from Thermo Fisher, Aimmune, DBV, Before Brands, multiple state allergy societies, the American College of Allergy Asthma and Immunology, the Eurpoean Academy of Allergy and Clinical Immunology; is an associate editor for the <i>Annals of Allergy, Asthma, and Immunology</i>; and is a member of the Joint Taskforce on Allergy Practice Parameters.Spencer Kimball is a Director of Emerson College Polling; a member of the American Association for Public Opinion Research (AAPOR) and President of the New England Chapter of AAPOR in 2018–2019; an advisor to the Florida Atlantic University Business and Economic Polling Initiative and the City University of New York (CUNY) SPH Foundation, LLC.Audrey DunnGalvin acts as a consultant for Aimmune Therapeutics and DBV Technologies. She has also received research grants from National Children’s Research Centre, Ireland, and the Food Allergy Research and Resource Program (University of Nebraska-Lincoln).Elissa Abrams is a collaborator with the Institute for Health Metrics and Evaluation, is on the National Advisory Board for Food Allergy Canada, and is on the National Food Allergy Action Plan Action Steering Team for Food Allergy Canada.Marcus Shaker is a member of the Joint Taskforce on Allergy Practice Parameters; has a family member who is CEO of Altrix Medical; serves on the Editorial Board of the <i>Journal of Food Allergy</i> and the <i>Annals of Allergy, Asthma, and Immunology</i>.Giselle Mosnaim received research grant support from Astra Zeneca, GlaxoSmithKline, and Propeller Health; owned stock in Electrocore; and served as a consultant and/or member of a scientific advisory board for GlaxoSmithKline, Sanofi-Regeneron, Teva, Novartis, Astra Zeneca, Boehringer Ingelheim, and Propeller Health.Pasquale Comberiati, Nikita A Nekliudov, Oleg Blyuss, Martin Teufel: no relevant financial conflicts to disclose.Daniel Munblit reports giving paid lectures for Bayer and received funding from the 5–100 Russian Academic Excellence Project.
: Not applicable.
Free to read: This content has been made available to all.